| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | Canada | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | Australia | 2 | |
| #6 | China | 2 | |
| #7 | Japan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Measurement | |
| #5 | Medical technology | |
| #6 | Foods and drinks | |
| #7 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies | |
| #6 | Analysing materials | |
| #7 | Animal care | |
| #8 | Enzymes | |
| #9 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Merchant Fahar | 25 |
| #2 | Fidai Shafique | 6 |
| #3 | Fahar Merchant | 2 |
| #4 | Merchant Rosemina | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020160639A1 | Il-4r as a biomarker in cancer | |
| WO2019239213A2 | Uses and methods for oncolytic virus targeting of il-4/il-13 and fusions thereof | |
| AU2018347796A1 | IL-4-fusion formulations for treatment of central nervous system (CNS) tumors | |
| CA3067909A1 | Uses and methods for il-2 superagonists, agonists, and fusions thereof | |
| CA2925421A1 | Interleukin-2 fusion proteins and uses thereof | |
| EP3049526A1 | Interleukin-4 receptor-binding fusion proteins and uses thereof |